Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benvitimod Cream Retreatment in Mild to Moderate Psoriasis
NCT05326659Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Apr 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Psoriasis vulgaris (PV) comparing Benvitimod Cream with Placebo (2 arms). Primary endpoint: Proportion of participants with >=75% improvement in Psoriasis Area and Severity Index at 12 weeks. Status: unknown.
02
Drugs
Benvitimod Cream
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT05326659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05326659.